Literature DB >> 16246325

Comparison of antibody array substrates and the use of glycerol to normalize spot morphology.

Eric W Olle1, James Messamore, Michael P Deogracias, Shannon D McClintock, Timothy D Anderson, Kent J Johnson.   

Abstract

Antibody microarrays are a high-throughput proteomic technology used to examine the expression of multiple proteins in complex solutions. Antibody microarrays can be manufactured on a variety of commercially available activated glass or coated slides. The goal of this study was to compare Hydrogeltrade mark, nitrocellulose, aldehyde-silane and epoxy-silane slides to determine the amount of antibody bound. The optimal substrate was defined as one that bound the greatest amount of antibody with minimal background. Our studies found that epoxy-silane enhanced surface (ES) slides gave the greatest degree of binding along with a minimal background. However, larger antibody microarrays showed variability in spot size, high intra-spot coefficient of variation and drying artifacts. Increasing the amount of glycerol in the spotting buffer caused a dose-dependent improvement in overall spot morphology. Glycerol was tested on 128 different antibodies and showed decreased: mean spot diameter, intra-spot coefficient of variation and drying artifacts. These studies revealed that the optimal slide substrate was epoxy-silane ES microarray slides. Furthermore, glycerol could normalize spot size, decrease intra-spot coefficient of variability, decrease drying artifacts and increase antibody-spotting density.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246325     DOI: 10.1016/j.yexmp.2005.09.003

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  13 in total

1.  Controlling microarray spot morphology with polymer liftoff arrays.

Authors:  Jose M Moran-Mirabal; Christine P Tan; Reid N Orth; Eric O Williams; Harold G Craighead; David M Lin
Journal:  Anal Chem       Date:  2007-02-01       Impact factor: 6.986

Review 2.  Reverse phase protein microarrays advance to use in clinical trials.

Authors:  Claudius Mueller; Lance A Liotta; Virginia Espina
Journal:  Mol Oncol       Date:  2010-10-16       Impact factor: 6.603

3.  A protein multiplex microarray substrate with high sensitivity and specificity.

Authors:  Dolores A Fici; William McCormick; David W Brown; John E Herrmann; Vikram Kumar; Zuheir L Awdeh
Journal:  J Immunol Methods       Date:  2010-10-23       Impact factor: 2.303

4.  Integrated imaging instrument for self-calibrated fluorescence protein microarrays.

Authors:  A P Reddington; M R Monroe; M S Ünlü
Journal:  Rev Sci Instrum       Date:  2013-10       Impact factor: 1.523

5.  Functionalized Polymer Microgel Particles Enable Customizable Production of Label-Free Sensor Arrays.

Authors:  Mark A Lifson; Jared A Carter; Benjamin L Miller
Journal:  Anal Chem       Date:  2015-07-15       Impact factor: 6.986

6.  Evaluation of surface chemistries for antibody microarrays.

Authors:  Shannon L Seurynck-Servoss; Amanda M White; Cheryl L Baird; Karin D Rodland; Richard C Zangar
Journal:  Anal Biochem       Date:  2007-07-25       Impact factor: 3.365

7.  Investigation of non-nucleophilic additives for the reduction of morphological anomalies in protein arrays.

Authors:  Charles R Mace; Amrita R Yadav; Benjamin L Miller
Journal:  Langmuir       Date:  2008-10-17       Impact factor: 3.882

8.  Facile chemical functionalization of proteins through intein-linked yeast display.

Authors:  Carrie J Marshall; Nitin Agarwal; Jeet Kalia; Vanessa A Grosskopf; Nicholas A McGrath; Nicholas L Abbott; Ronald T Raines; Eric V Shusta
Journal:  Bioconjug Chem       Date:  2013-08-22       Impact factor: 4.774

9.  Apparent thixotropic properties of saline/glycerol drops with biotinylated antibodies on streptavidin-coated glass slides: implications for bacterial capture on antibody microarrays.

Authors:  David M Albin; Andrew G Gehring; Sue A Reed; Shu-I Tu
Journal:  Sensors (Basel)       Date:  2009-02-16       Impact factor: 3.576

10.  Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Authors:  Adriana Aguilar-Mahecha; Christiane Cantin; Maureen O'Connor-McCourt; Andre Nantel; Mark Basik
Journal:  Proteome Sci       Date:  2009-04-06       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.